Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)

NCT01887379 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroretentive Drug Formulation of Furosemide
Oedema

Interventions

DRUG: GRDF furosemide

Sponsor

LTS Lohmann Therapie-Systeme AG